Potential leveraged buyout of dermapharm holding se: business plan, valuation, due diligence, exit and returns

Höfer, Marco

http://hdl.handle.net/10362/142666

Utilize este identificador para referenciar este registo.

Nome:	Descrição:	Tamanho:	Formato:
2020-21_fall_44197_marco-hofer.pdf		2.5 MB	Adobe PDF	Ver/Abrir

Contacte-nos

Autores

Höfer, Marco

Orientador(es)

Spratley, Inês Simões Lopo de Carvalho

Resumo(s)

The following paper focuses on developing an investment thesis and a respective value creation strategy for the potential leveraged buyout of DermapharmHolding SE, a German developer, producer, and distributor of niche prescription and over-the-counter pharmaceuticals. Hence, this thesis determines an entry value based on distinguished valuation methods and assesses the value upon exit by creating a business plan that incorporates the proposed value creation strategies to derive potential returns for investors. Qualitatively, this work evaluates potential exit opportunities and highlights the key points to be investigated during a due diligence.

Palavras-chave

Valuation Business plan Corporate finance Private equity Capital structure Leveraged buyout Due diligence Field lab Exit and returns Dermapharm se holding Specialty pharmaceuticals & generics